slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 206,971-207,000
Pages 10,126
Rows per page 30
Component
206,971-207,000 of 303,780
17
Includes detailed footnotes regarding debt terms and equity instruments.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
18
Advantage Solutions | Investor Presentation Deck | 25 slidesAdvantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
19
Advantage Solutions | Investor Presentation Deck | 25 slidesAdvantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · Team1 hit
20
Includes footnotes (1) through (9) referenced in the table rows.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
21
This is a standard financial disclosure slide for non-GAAP metrics.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
22
This is a standard financial disclosure table showing historical adjustments to GAAP net income.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
23
This is part 4 of 6 of a non-GAAP reconciliation series.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
24
This is a standard financial disclosure slide for non-GAAP metrics.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
25
This is the final slide in a series of non-GAAP reconciliation disclosures.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
01
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
02
Includes a hub-and-spoke diagram illustrating the effects of pathogenic autoantibodies.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Problem Identification1 hit
03
The slide uses a visual process flow to explain the competitive inhibition mechanism.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
04
The slide uses a timeline-based process flow to illustrate the clinical trial protocol.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
05
Standard clinical trial participant flow diagram.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
06
Red boxes highlight key clinical history metrics: time since diagnosis, splenectomy history, prior therapies, and concurrent therapy usage.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Agitation1 hit
07
The slide uses a hierarchical testing procedure for statistical significance.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Solution1 hit
08
The chart includes error bars and a table of participant counts at the bottom.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Before-After Comparison1 hit
09
The slide uses a stacked bar chart to visualize the response rates and a table to detail specific IWG criteria outcomes.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Comparative Analysis1 hit
10
The chart uses a back-to-back bar structure to visualize the distribution of disease control duration.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
11
The chart displays point estimates and 95% confidence intervals for the treatment effect across multiple clinical and demographic categories.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Loop · Mece Breakdown1 hit
12
The chart displays a significant, sustained reduction in IgG levels for the treatment group compared to placebo.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
13
The table compares adverse events (TEAEs) and specific common events between treatment and placebo groups.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
14
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
15
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
01
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
02
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
03
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
04
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
05
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
10
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit